Dana-Farber Cancer Institute ( Site 4047)

Boston, Massachusetts 02115

0 studies enrolling now · 1 studies all time

What they study most

Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma

Studies at this site

• A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04) — Running, not enrolling